# The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2020, Regulation 16: Substitution of regulation 3(12)


For regulation 3(12) substitute—
“(12) In regulation 20A (duties of the Authority in relation to application of the Single European Code)—
(a) in the heading, after “the Single European Code” insert “in relation to Northern Ireland”;
(b) in paragraph (1), for “The Authority” substitute “In relation to Northern Ireland, the Authority”;
(c) for paragraph (3) substitute—
“(3) In relation to Northern Ireland, the Authority must take steps to enable the information specified in Annex VIII to be recorded in the EU Tissue Establishment Compendium in relation to each licence holder.”;
(d) omit paragraph (4);
(e) for paragraph (5) substitute—
“(5) The Authority must take the steps mentioned in paragraph (3) to enable the information mentioned in that paragraph to be recorded before the end of the period of 10 working days beginning with the day on which the person becomes a licence holder.”;
(f) in paragraph (7), for the words before sub-paragraph (a) substitute—
“Where this paragraph applies, the Authority must take steps to enable the information to be corrected or updated—”;
(g) in paragraph (11), for the definition of “relevant state”, substitute—
““relevant state” means an EEA state;”.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213027/regulation/16 (the official version)
Page: https://openlegislation.uk/draft-human-tissue-quality-and-safety-for-human-application-amendment-eu-exit-regulations-2020/regulation-16
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.